Raymond James Financial Services Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $307K | Buy |
+4,197
| New | +$307K | ﹤0.01% | 2935 |
|
|
2024
Q2 | – | Sell |
-4,981
| Closed | -$345K | – | 3517 |
|
|
2024
Q1 | $345K | Sell |
4,981
-1,459
| -23% | -$101K | ﹤0.01% | 2752 |
|
|
2023
Q4 | $461K | Sell |
6,440
-89
| -1% | -$6.37K | ﹤0.01% | 2474 |
|
|
2023
Q3 | $340K | Sell |
6,529
-2,290
| -26% | -$119K | ﹤0.01% | 2560 |
|
|
2023
Q2 | $558K | Buy |
8,819
+2,770
| +46% | +$175K | ﹤0.01% | 2279 |
|
|
2023
Q1 | $328K | Buy |
6,049
+1,859
| +44% | +$101K | ﹤0.01% | 2594 |
|
|
2022
Q4 | $222K | Buy |
+4,190
| New | +$222K | ﹤0.01% | 2800 |
|